Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$3.47 - $4.61 $317,126 - $421,312
91,391 Added 72.92%
216,717 $890,000
Q4 2023

Feb 05, 2024

SELL
$3.38 - $4.58 $73,386 - $99,440
-21,712 Reduced 14.77%
125,326 $528,000
Q3 2023

Nov 06, 2023

SELL
$4.28 - $6.57 $14,393 - $22,094
-3,363 Reduced 2.24%
147,038 $635,000
Q2 2023

Jul 27, 2023

SELL
$5.9 - $6.95 $502,933 - $592,438
-85,243 Reduced 36.17%
150,401 $991,000
Q1 2023

May 02, 2023

SELL
$6.18 - $7.99 $268,267 - $346,837
-43,409 Reduced 15.56%
235,644 $1.6 Million
Q4 2022

Feb 10, 2023

SELL
$6.87 - $10.96 $60,153 - $95,965
-8,756 Reduced 3.04%
279,053 $2.06 Million
Q4 2022

Feb 09, 2023

SELL
$6.87 - $10.96 $30,440 - $48,563
-4,431 Reduced 1.52%
287,809 $2.13 Million
Q3 2022

Nov 02, 2022

BUY
$9.44 - $11.76 $172,988 - $215,502
18,325 Added 6.69%
292,240 $2.89 Million
Q2 2022

Aug 01, 2022

BUY
$9.31 - $11.84 $142,759 - $181,554
15,334 Added 5.93%
273,915 $2.99 Million
Q1 2022

May 04, 2022

SELL
$10.84 - $16.55 $22,829 - $34,854
-2,106 Reduced 0.81%
258,581 $2.83 Million
Q4 2021

Feb 07, 2022

BUY
$15.69 - $21.14 $81,619 - $109,970
5,202 Added 2.04%
260,687 $4.09 Million
Q3 2021

Nov 02, 2021

BUY
$15.35 - $21.27 $1.83 Million - $2.54 Million
119,259 Added 87.54%
255,485 $4.38 Million
Q2 2021

Aug 03, 2021

BUY
$15.71 - $21.51 $1.33 Million - $1.82 Million
84,772 Added 164.75%
136,226 $2.93 Million
Q1 2021

May 04, 2021

BUY
$13.42 - $20.28 $356,770 - $539,143
26,585 Added 106.9%
51,454 $773,000
Q4 2020

Feb 01, 2021

BUY
$9.77 - $13.81 $70,822 - $100,108
7,249 Added 41.14%
24,869 $327,000
Q3 2020

Nov 09, 2020

BUY
$9.32 - $12.02 $164,218 - $211,792
17,620 New
17,620 $170,000
Q2 2020

Aug 07, 2020

SELL
$9.66 - $12.02 $70,923 - $88,250
-7,342 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$7.5 - $16.8 $21,360 - $47,846
-2,848 Reduced 27.95%
7,342 $76,000
Q4 2019

Feb 06, 2020

BUY
$12.38 - $17.47 $33,723 - $47,588
2,724 Added 36.49%
10,190 $167,000
Q4 2019

Feb 04, 2020

SELL
$12.38 - $17.47 $7,923 - $11,180
-640 Reduced 7.9%
7,466 $95,000
Q3 2019

Nov 12, 2019

BUY
$12.27 - $15.79 $64,319 - $82,771
5,242 Added 183.03%
8,106 $108,000
Q2 2019

Aug 15, 2019

SELL
$13.37 - $18.85 $66,555 - $93,835
-4,978 Reduced 63.48%
2,864 $40,000
Q1 2019

May 03, 2019

BUY
$17.59 - $31.05 $137,940 - $243,494
7,842 New
7,842 $144,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.